Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Trading banner 1
Trading banner 2
Trading banner 3
Trading banner 4
Trading banner 5
Trading banner 6
Trading banner 7
Trading banner 8
Trading banner 9
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell ADMA Biologics Inc (ADMA) – ADMA Biologics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ADMA trades at $9.19, up 0.88% today, amid bearish technical signals and ongoing securities fraud investigations. The stock faces pressure from channel stuffing allegations, yet maintains strong profitability with a 28.8% net margin and 35.56% ROE. Recent earnings beat expectations in two of the last three quarters, but legal scrutiny overshadows fundamental strength.
Outlook is clouded by legal risks, though fundamentals remain robust; the stock presents high risk with potential reward if legal concerns resolve favorably. Investors should weigh strong earnings against significant litigation overhangs.
Read full analysis

Key Stats

  • Market Cap
    $2.21B
  • Sector
    Health
  • 3M Drawdown
    -54.65%
  • Enterprise Value
    $2.20B
  • Dividend Yield
    -
  • Trading Activity
    49% Buy | 51% Sell
  • Typical Hold Time
    5 days
$9.48
52W Low: $8.29
26 Mar 2026
52W High: $24.51
28 Apr 2025

ADMA Biologics Inc (ADMA) is currently valued at a market capitalization of $2.21B, with an enterprise value of $2.20B. Over the past 52 weeks, ADMA Biologics Inc has traded between a low of $8.29 and a high of $24.51, highlighting its annual price range. Over the past three months, ADMA Biologics Inc has recorded a drawdown of -54.65%, reflecting recent price volatility. ADMA Biologics Inc offers a dividend yield of -. On average, investors hold ADMA Biologics Inc for approximately 5 days, indicating typical investor behavior on the platform.

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.


Technical Indicators
|
|
|
Overall Summary
Bearish (8)Neutral (9)Bullish (10)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $2.21B
  • Sector
    Health
  • 3M Drawdown
    -54.65%
  • Enterprise Value
    $2.20B
  • Dividend Yield
    -
  • Trading Activity
    49% Buy | 51% Sell
  • Typical Hold Time
    5 days
$9.48
52W Low: $8.29
26 Mar 2026
52W High: $24.51
28 Apr 2025

ADMA Biologics Inc (ADMA) is currently valued at a market capitalization of $2.21B, with an enterprise value of $2.20B. Over the past 52 weeks, ADMA Biologics Inc has traded between a low of $8.29 and a high of $24.51, highlighting its annual price range. Over the past three months, ADMA Biologics Inc has recorded a drawdown of -54.65%, reflecting recent price volatility. ADMA Biologics Inc offers a dividend yield of -. On average, investors hold ADMA Biologics Inc for approximately 5 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!